Report cover image

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Publisher BCC Research
Published Jan 31, 2024
Length 157 Pages
SKU # WA18475484

Description

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets



Report Scope:

This research study analyzes the state of prostate cancer care, including screening, detection and treatment, offers revenue forecasts, assesses future trends, and provides recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and provides forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by product type and region from 2023 through 2028. Genetic testing for inherited prostate cancer risk assessment is beyond the scope of the report.

Report Includes:

31 data tables and 63 additional tables

An overview of the global market for the technologies for prevention and treatment of prostate cancer

Analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028

Evaluation of the current market size and revenue growth prospects specific to prevention and treatment of prostate cancer, accompanied by a market share analysis by test type, treatment type, drug type and geographic region

Description of several types of prostate cancer, namely acinar adenocarcinoma, ductal adenocarcinoma, transitional cell (or urothelial) cancer, small cell prostate cancer and carcinoid and sarcomas

Description of biomarker tests such as the prostate-specific antigen (PSA) test, digital rectal exam (DRE) and prostate biopsy, and a discussion on their advantages and limitations

Information on poly adenosine diphosphate-ribose polymerase (PARP) inhibitors, their limitations and approvals related to their use as targeted therapy for prostate cancer

Coverage of approvals for metastatic castration resistant prostate cancer (mCRPC), and collaborations and licensing agreements for the treatment of prostate cancer

Evaluation of the current and future market potential and an analysis of the regulatory framework and reimbursement scenarios

Review of patents, product pipelines, ESG trends and emerging technologies related to prevention and treatment of prostate cancer

Market share analysis of the key companies in the industry and coverage of mergers & acquisitions, joint ventures, collaborations, partnerships and other market strategies

Profiles of leading market participants

Companies Mentioned

ABBOTT
ACCURAY INC.
ASTELLAS PHARMA INC.
ASTRAZENECA PLC
BAYER AG
DANAHER CORP.
DENDREON PHARMACEUTICALS LLC
ELEKTA
F. HOFFMANN-LA ROCHE LTD.
JOHNSON & JOHNSON SERVICES INC.
PFIZER INC.
SANOFI
SIEMENS HEALTHINEERS AG

Table of Contents

157 Pages
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
What's New in this Update?
Methodology and Information Sources
Geographic Breakdown
Segmentation Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Chapter 3 Market Overview
Overview of Cancer
Prostate Cancer
Biology of Prostate Cancer
Symptoms
Screening
Diagnosis
Localized Prostate Cancer
Metastatic Prostate Cancer
Watchful Waiting or Active Surveillance
Treatment
Conclusions
Chapter 4 Market Dynamics
Overview
Market Drivers
Increasing Prevalence of Prostate Cancer
Active Surveillance and Screening
Personalized Care
Approvals for Metastatic Castration-Resistant Prostate Cancer
Collaborations and Licensing Agreements
Market Challenges
Loss of Exclusivity and Genericization
Shortage of Care Providers and Other Resources
Market Opportunities
Chapter 5 Screening and Diagnosis Market by Test Type
Market Overview
Biomarker Tests
PSA Tests
Limitations of PSA Tests
Biomarker Tests for Early Prostate Cancer Detection in Elevated PSA Settings
Digital Rectal Exam
Limitations of DREs
Prostate Biopsy
Grade (Gleason Score) of Prostate Cancer
Prostatic Intraepithelial Neoplasia
Atypical Small Acinar Proliferation
Proliferative Inflammatory Atrophy
Intraductal Carcinoma of the Prostate
Limitations of Prostate Biopsies
Imaging Technologies for Prostate Cancer
Market for Prostate Cancer Screening/Diagnosis, by Test Type
Biomarker Tests
DREs
Prostate Biopsies
Chapter 6 Pharmaceuticals Market by Drug Type
Market Overview
Hormone Therapy
Androgen Deprivation Therapy
Antiandrogen Therapies
Hormone Therapy Uses in Prostate Cancer Treatment
Targeted Therapy
PARP Inhibitors
Radioligand Therapies
Small Molecule Targeted Agents
Monoclonal Antibodies
Chemotherapy
Immunotherapy
Market Revenue, by Drug Type
Hormone Therapy
Targeted Therapy
Immunotherapy
Chemotherapy
Chapter 7 Market for Surgery and Radiation Therapy by Treatment Type
Market Overview
Active Surveillance
Radical Prostatectomy
Robotic Prostatectomy
Open Radical Prostatectomy
Laparoscopic Prostatectomy
Radical Prostatectomy Market Revenue
Radiation Therapy
External Beam Radiation Therapy
Brachytherapy
Combined Radiation Therapy
Radiation Therapy Device Market Revenue
Chapter 8 Market Breakdown by Region
Market Overview
Market Revenue, by Region
North America
Market Revenue, by Product Type
Europe
Market Revenue, by Product Type
Asia-Pacific
Market Revenue, by Product Type
Rest of the World (RoW)
Market Revenue, by Product Type
Chapter 9 Emerging Technologies and Developments
Overview
Liquid Biopsy
Multiparametric MRI
Homologous Recombination Repair Gene Mutation
Advanced Radiotherapy Techniques
AI and Machine Learning
Chapter 10 Pipeline Analysis
Overview
By Company
Chapter 11 Competitive Intelligence
Overview
Screening and Diagnosis Market
Market for Radiation Therapy Devices
Pharmaceuticals Market
Chapter 12 Company Profiles
ABBOTT
ACCURAY INC.
ASTELLAS PHARMA INC.
ASTRAZENECA PLC
BAYER AG
DANAHER CORP.
DENDREON PHARMACEUTICALS LLC
ELEKTA
F. HOFFMANN-LA ROCHE LTD.
JOHNSON & JOHNSON SERVICES INC.
PFIZER INC.
SANOFI
SIEMENS HEALTHINEERS AG
Chapter 13 Appendix: Abbreviations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us